Nishii Y - Search Results

1

Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study.

Kogure Y, Kada A, Hashimoto H, Atagi S, Takiguchi Y, Saka H, Ebi N, Inoue A, Kurata T, Fujita Y, Nishii Y, Itani H, Endo T, Saito AM, Shibayama T, Yamamoto N, Gemma A. Kogure Y, et al. Among authors: nishii y. JTO Clin Res Rep. 2023 Apr 6;4(6):100514. doi: 10.1016/j.jtocrr.2023.100514. eCollection 2023 Jun. JTO Clin Res Rep. 2023. PMID: 37304652 Free PMC article.

2

Efficacy of osimertinib in a patient with non-small cell lung cancer harboring epithelial growth factor receptor exon 19 deletion/T790M mutation, with poor performance status.

Nishii Y, Hataji O, Ito K, Watanabe F, Kobayashi T, D'Alessandro-Gabazza C, Toda M, Taguchi O, Yamamoto N, Gabazza EC. Nishii Y, et al. Mol Clin Oncol. 2018 Feb;8(2):246-249. doi: 10.3892/mco.2017.1522. Epub 2017 Nov 29. Mol Clin Oncol. 2018. PMID: 29399354 Free PMC article.

3

Guide sheath versus non-guide sheath method for endobronchial ultrasound-guided biopsy of peripheral pulmonary lesions: a multicentre randomised trial.

Oki M, Saka H, Imabayashi T, Himeji D, Nishii Y, Nakashima H, Minami D, Okachi S, Mizumori Y, Ando M. Oki M, et al. Among authors: nishii y. Eur Respir J. 2022 May 26;59(5):2101678. doi: 10.1183/13993003.01678-2021. Print 2022 May. Eur Respir J. 2022. PMID: 34625482 Free article. Clinical Trial.

4

Value of adding ultrathin bronchoscopy to thin bronchoscopy for peripheral pulmonary lesions: A multicentre prospective study.

Oki M, Saka H, Himeji D, Imabayashi T, Nishii Y, Ando M. Oki M, et al. Among authors: nishii y. Respirology. 2023 Feb;28(2):152-158. doi: 10.1111/resp.14397. Epub 2022 Oct 26. Respirology. 2023. PMID: 36288803

5

Physical Activity Estimated by the Wearable Device in Lung Disease Patients: Exploratory Analyses of Prospective Observational Study.

Ito K, Esumi M, Esumi S, Suzuki Y, Sakaguchi T, Fujiwara K, Nishii Y, Yasui H, Taguchi O, Hataji O. Ito K, et al. Among authors: nishii y. J Clin Med. 2023 Jun 30;12(13):4424. doi: 10.3390/jcm12134424. J Clin Med. 2023. PMID: 37445463 Free PMC article.

6

Assessment of chemotherapy regimens on radiation pneumonitis in patients with unresectable stage III non-small-cell lung cancer after definitive chemoradiotherapy.

Sakaguchi T, Ito K, Furuya N, Morikawa K, Fujiwara K, Nishii Y, Inoue T, Hataji O, Mineshita M. Sakaguchi T, et al. Among authors: nishii y. Thorac Cancer. 2021 Jul;12(13):2024-2030. doi: 10.1111/1759-7714.14005. Epub 2021 May 18. Thorac Cancer. 2021. PMID: 34002492 Free PMC article.

7

Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report.

Nishii Y, Furuhashi K, Ito K, Sakaguchi T, Suzuki Y, Fujiwara K, Yasuma T, Kobayashi T, D'Alessandro-Gabazza CN, Gabazza EC, Taguchi O, Hataji O. Nishii Y, et al. Pharmaceuticals (Basel). 2022 Jul 19;15(7):889. doi: 10.3390/ph15070889. Pharmaceuticals (Basel). 2022. PMID: 35890187 Free PMC article.

8

Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma.

Ito A, Tarukawa T, Suzuki Y, Sakaguchi T, Ito K, Fujiwara K, Nishii Y, Taguchi O, Yasui H, Takao M, Hataji O. Ito A, et al. Among authors: nishii y. Anticancer Res. 2023 Nov;43(11):5197-5204. doi: 10.21873/anticanres.16721. Anticancer Res. 2023. PMID: 37909981

9

Physical Activity Using a Wearable Device as an Alternative to Performance Status in Patients With Advanced Lung Cancer.

Ito K, Suzuki Y, Sakaguchi T, Fujiwara K, Nishii Y, Yasui H, Taguchi O, Hataji O. Ito K, et al. Among authors: nishii y. JAMA Oncol. 2024 May 1;10(5):648-651. doi: 10.1001/jamaoncol.2024.0023. JAMA Oncol. 2024. PMID: 38546663 Free PMC article.

10

Clinical importance of the range of detectable variants between the Oncomine Dx target test and a conventional single-gene test for EGFR mutation.

Sakaguchi T, Iketani A, Esumi S, Esumi M, Suzuki Y, Ito K, Fujiwara K, Nishii Y, Katsuta K, Yasui H, Taguchi O, Hataji O. Sakaguchi T, et al. Among authors: nishii y. Sci Rep. 2023 Aug 23;13(1):13759. doi: 10.1038/s41598-023-40271-w. Sci Rep. 2023. PMID: 37612335 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

321 results

Search Page